Linked Life Data

12718725

Source:http://linkedlifedata.com/resource/pubmed/id/12718725

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
pubmed:issue
3
pubmed:dateCreated
2003-4-29
pubmed:abstractText
Etiologics is an innovative drug discovery company that, unlike most new companies in this sector, has a balanced portfolio of ethylnitrosourea (ENU) technology, animal models of disease, in vitro cell function models, and expertise in drug discovery, which spans the whole drug discovery process. The aim of the company is to identify and develop novel effective therapies for respiratory and metabolic diseases where there is a high unmet medical need. Etiologics also offers partners access to its ENU technology and/or preclinical respiratory models/expertise to enable them to identify/validate new targets and enhance the value of in-house programs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1462-2416
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
351-7
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Etiologics ltd.
pubmed:affiliation
Etiologics Ltd, Medical Research Council, Harwell, Oxfordshire, OX11 0RD, UK. david.campbell@etiologics.com
pubmed:publicationType
Journal Article